Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-21FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Hydralazine hydrochloride (generic) from Heritage Pharmaceuticals (d/b/a Avet) to support co…
-
FDA approval · 2025-04-17FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for olmesartan medoxomil from Jubilant Cadista Pharmaceuticals, approving the generic product under …
-
FDA approval · 2025-04-17FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for Nicardipine hydrochloride from Epic Pharma, LLC, under the ANDA process. This represents a s…
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental NDA for the extended-release form of diltiazem hydrochloride.
-
FDA approval · 2025-04-16FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride by Oceanside Pharmaceuticals.
-
FDA approval · 2025-04-16FDA Approved: BISOPROLOL FUMARATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for BISOPROLOL FUMARATE from Rising Pharma Holdings, Inc., establishing a generic version of this beta…
-
FDA approval · 2025-04-15FDA Approved: GUANFACINE — Original Application (Advagen Pharma Limited)
The FDA approved Advagen Pharma Limited's generic guanfacine under an original ANDA.
-
FDA approval · 2025-04-10FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc., repre…
-
FDA approval · 2025-03-28FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for nicardipine hydrochloride from Cipla USA Inc., indicating an update to this generic product'…
-
FDA approval · 2025-03-24FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hikma Pharmaceuticals USA Inc. (ANDA 077761), updating the regulatory sta…
-
FDA approval · 2025-03-19FDA Approved: CARVEDILOL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for carvedilol from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2025-03-17FDA Approved: ATENOLOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Atenolol from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2025-03-17FDA Approved: HEMICLOR — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approves HemiclOR (chlorthalidone) through an Original Application by Ingenus Pharmaceuticals, LLC.
-
FDA approval · 2025-03-12FDA Approved: TELMISARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for Telmisartan from Jubilant Cadista Pharmaceuticals Inc., confirming continued approval of this ge…
-
FDA approval · 2025-03-07FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for Bisoprolol Fumarate from TruPharma LLC, validating the generic product under ANDA075643.
-
FDA approval · 2025-03-04FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for benazepril hydrochloride (generic) manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet …
-
FDA approval · 2025-03-03FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Lifestar Pharma LLC)
The FDA approved a generic fixed-dose combination of telmisartan and hydrochlorothiazide (ANDA 218406) for hypertension, manufactured by Lif…
-
FDA approval · 2025-02-21FDA Approved: DILTIAZEM HYDROCHLORIDE IN SODIUM CHLORIDE — Original Application (WG Critical Care, LLC)
FDA approved a new injectable diltiazem hydrochloride in sodium chloride under an original NDA from WG Critical Care, LLC. This parenteral f…
-
FDA approval · 2025-02-21FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Cardene IV (nicardipine hydrochloride) from Baxter Healthcare Corporation, confirming the in…
-
FDA approval · 2025-02-21FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for spironolactone, establishing a generic version of the diuretic. Spironolac…
-
FDA approval · 2025-02-14FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic amlodipine and olmesartan medoxomil fixed-dose combination (ANDA 209591).
-
EMA approval · 2025-01-29EMA Authorised: Edarbi (azilsartan medoxomil) — Takeda Pharma A/S
The European Medicines Agency authorised Edarbi (azilsartan medoxomil) for hypertension; Takeda Pharma A/S is the marketing authorisation ho…
-
EMA approval · 2025-01-29EMA Authorised: Irbesartan Teva (irbesartan) — Teva B.V.
The European Medicines Agency authorised a generic irbesartan product by Teva B.V. for the treatment of hypertension.
-
FDA approval · 2025-01-28FDA Approved: INZIRQO — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved INZIRQO, a brand-name hydrochlorothiazide, under ANI Pharmaceuticals' original application.